• Home
  • Media
  • News
  • LEO Pharma strengthens global leadership team with appointment of new EVP People and Communications

LEO Pharma strengthens global leadership team with appointment of new EVP People & Communications

Ballerup, August 18, 2020 – LEO Pharma A/S today announced that Dennis Schmidt Pedersen will join the executive leadership team as Executive Vice President Global People & Communications, effective September 1, 2020.

Schmidt Pedersen joined LEO Pharma in 2017 as Senior Human Resource Business Partner and is currently Global HR Lead. Before joining LEO Pharma, Dennis was Chief Human Resources Officer at SOBI, and held positions at Ferring Pharmaceuticals, Genzyme as well as Takeda. He has a background as Army Officer in the Danish Army.


“Dennis Schmidt Pedersen brings a wealth of experience as HR leader in the life-sciences industry to his new role, having helped companies during major strategic shifts such as mergers and acquisitions and expansion into new therapeutic areas. With his demonstrated success in building effective organizations, he will be a strong support in executing on our ambition to become a global leader in medical dermatology, positioning ourselves for long-term growth driven by innovation,” said Catherine Mazzacco, President and CEO of LEO Pharma. “I am also very pleased that we promote an internal candidate for this role, underlining the quality of our internal talent pool and talent work,” Catherine Mazzacco continued.


Dennis Schmidt Pedersen succeeds Mette Vestergaard who has decided to leave LEO Pharma for an external opportunity.

About LEO Pharma

The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit. Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of re-search and development to advance the science of der-matology, setting new standards of care for people with skin conditions. LEO Pharma is headquartered in Denmark with a global team of 6,000 people, serving 92 million patients in 130 countries. For more information about LEO Pharma, visit www.leo-pharma.com.

CONTACT US

Henrik Kyndlev

Director, Global External Communications
Tel: +45 3140 6180